ELV
Elevance Health, Inc.
NYSE · Healthcare · Medical - Healthcare Plans · US
$410.95
−0.80%Next report
Analyst consensus
- Next report date
- Oct 21, 2026
- EPS estimate
- $4.66
- Revenue estimate
- $49.3B
Latest reported
- Last report date
- Jul 15, 2026
- EPS actual
- $7.45
- EPS estimate
- $6.21
- Revenue actual
- $49.8B
- Revenue estimate
- $48.9B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- +15.9%
- Revenue beats (12Q)
- 10
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $447
- PT range
- $393 – $482
- Analysts
- 11
8 Buy3 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 15, 2026 | $6.21 | $7.45 | Beat 19.97% | $49.8B |
| Apr 22, 2026 | $11 | $13 | Beat 14.05% | $49.5B |
| Jan 28, 2026 | $3.10 | $3.33 | Beat 7.42% | $49.7B |
| Oct 21, 2025 | $4.93 | $6.03 | Beat 22.31% | $50.7B |
| Jul 17, 2025 | $8.91 | $8.84 | Miss -0.79% | $49.8B |
| Jan 23, 2025 | $3.84 | $3.84 | Miss -0.08% | $45.4B |
| Oct 17, 2024 | $9.67 | $8.37 | Miss -13.44% | $45.1B |
| Jul 17, 2024 | $10 | $10 | Beat 1.05% | $43.6B |
| Apr 18, 2024 | $11 | $11 | Beat 1.00% | $42.6B |
| Jan 24, 2024 | $5.56 | $5.62 | Beat 1.13% | $42.6B |
| Oct 18, 2023 | $8.45 | $8.99 | Beat 6.42% | $42.8B |
| Jul 19, 2023 | $8.80 | $9.04 | Beat 2.69% | $43.7B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 21, 2026